Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The GRASP trial has completed recruitment and will now begin its follow up phase.

GRASP logo

The GRASP trial is looking at the best ways to treat shoulder pain in people with a rotator cuff disorder. We are testing two different types of physiotherapy treatment pathways routinely used to treat people with rotator cuff problems. The study is also investigating whether a corticosteroid injection in the shoulder joint before starting physiotherapy helps relieve pain and improve patient function more quickly.

Since early 2017, 708 participants have been enrolled into the GRASP trial across 20 NHS Hospital Trusts in England. We have now finished the recruitment part of this study. Over the next 12 months we will be asking participants to complete questionnaires at 8 weeks, 6 and 12 months after they first entered into the study asking them about how their health, activity and shoulder pain. The trial results are anticipated in the summer/autumn of 2020.

We are very grateful to all of the patients who are taking part in the GRASP trial and to the clinical and research staff at our participating NHS Hospital Trust’s (https://grasp.octru.ox.ac.uk/all-sites).

GRASP is funded by the National Institute for Health Research Health Technology Assessment Programme (ID: 15/26/06).

Similar stories

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.